Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition
NCT01161134
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Meloxicam
Sponsor
Dr. Reddy's Laboratories Limited